Design, synthesis and biological evaluation of 1,3-diphenylbenzo[f][1,7]naphthyrdines

Cited 11 time in scopus
Metadata Downloads
Title
Design, synthesis and biological evaluation of 1,3-diphenylbenzo[f][1,7]naphthyrdines
Author(s)
S K Arepalli; B Park; K Lee; H Jo; K Y Jun; Y Kwon; Jong Soon Kang; J K Jung; H Lee
Bibliographic Citation
Bioorganic & Medicinal Chemistry, vol. 25, no. 20, pp. 5586-5597
Publication Year
2017
Abstract
A novel series of twenty 1,3-diphenylbenzo[f][1,7]benzonaphthyrdine derivatives were designed and synthesized through intermolecular imino Diels-Alder reaction. Their in vitro cytotoxic activities were evaluated against six human cancer cell lines (NCIH23, HCT15, NUGC-3, ACHN, PC-3, and MDA-MB-231). Majority of synthesized compounds exhibited significant cytotoxic activities against all tested human cancer cell lines. Among them 4l, 4m, and 4o derivatives exhibited most promising cytotoxic activities. Furthermore these compounds were evaluated against human Topoisomerase IIα inhibition. Interestingly, the compound 4l exhibited 1.3 and 1.2 times more potent human Topoisomerase IIα inhibition than the reference drug etoposide in both 100 μM and 20 μM concentrations respectively. Molecular docking studies for the compound 4l have also been executed by Sybyl X-2.1 in which it reveals the binding site of the compound 4l with topo IIα DNA cleavage site where etoposide was situated. The benzo[f][1,7]naphthyridine ring was stacked between the DNA bases of the cleavage site
Keyword
1,3-Diphenylbenzo[f][1,7]benzonaphthyrdinesCytotoxic agentsHuman Topoisomerase IIα inhibitorsImino Diels-Alder reactionMolecular docking studies
ISSN
0968-0896
Publisher
Elsevier
Full Text Link
http://dx.doi.org/10.1016/j.bmc.2017.08.030
Type
Article
Appears in Collections:
Ochang Branch Institute > Division of National Bio-Infrastructure > Laboratory Animal Resource & Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.